What is NDC 72603-313?

72603-313 is the product NDC for Lansoprazole, Lansoprazole 15 mg/1 tablet, orally disintegrating, delayed release, listed with the FDA by NorthStar Rx LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

NorthStar Rx LLC, NDC labeler code 72603. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lansoprazole?

94 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lansoprazole NDC 72603-313 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72603-313Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72603-0313Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72603-313-10	7260303131072603031310	10 BLISTER PACK in 1 CARTON (72603-313-10) / 10 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK (72603-313-01)Marketed from Mar 28, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lansoprazole
Generic name (nonproprietary): lansoprazole
Active ingredients: Lansoprazole — 15 mg/1
Dosage form: Tablet, Orally disintegrating, Delayed release
Route: Oral
Labeler: NorthStar Rx LLCNDC labeler code 72603
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207167
Marketing start: Mar 28, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Inhibition Gastric Acid Secretion (Physiologic effect)Proton Pump Inhibitors (Mechanism)
Identifiers: Product ID 72603-313_ac051296-6fe3-4ab5-a001-cc3e06199a22SPL ID ac051296-6fe3-4ab5-a001-cc3e06199a22SPL set ID ac051296-6fe3-4ab5-a001-cc3e06199a22RxCUI 351260, 351261UNII 0K5C5T2QPGUPC 0372603314106, 0372603313109
Pharmacologic class: Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472603031310 followed by a unit qualifier and the quantity

Package 72603-0313-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 8, 2024.

Indications (excerpt from the label)

Lansoprazole delayed-release orally disintegrating tablets are proton pump inhibitors (PPIs) indicated for the: Treatment of active duodenal ulcer in adults. ( 1.1) Eradication of H. pylori to reduce the risk of duodenal ulcer recurrence in adults. ( 1.2 ) Maintenance of healed duodenal ulcers in adults. ( 1.3 ) Treatment of active benign gastric ulcer in adults. ( 1.4) Healing of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults. (1.5) Risk reduction of NSAID-associated gastric ulcer in adults. ( 1.6 ) Treatment of symptomatic gastroesophageal reflux disease (GERD) in adults and pediatric patients 1 year of age and older. (1.7) Treatment of erosive esophagitis…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72603-313

What is NDC 72603-313?: 72603-313 is the product NDC for Lansoprazole, Lansoprazole 15 mg/1 tablet, orally disintegrating, delayed release, listed with the FDA by NorthStar Rx LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lansoprazole.
What is the active ingredient?: Lansoprazole.
Who is the labeler?: NorthStar Rx LLC, NDC labeler code 72603. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lansoprazole?: 94 other product NDCs are listed under this name. See all Lansoprazole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lansoprazole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lansoprazole	Lansoprazole 30 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Cardinal Health 107, LLC	55154-8340	55154-8340-00
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed release pelletsOral	Preferred Pharmaceuticals Inc.	68788-4141	68788-4141-0368788-4141-0668788-4141-09
Lansoprazole	Lansoprazole 15 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Amazon.com Services LLC	72288-672	72288-0672-55
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Amazon.com Services LLC	72288-827	72288-0827-03
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed release pelletsOral	Safecor Health LLC	48433-051	48433-0051-08
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Medcore LLC	82461-713	82461-0713-30
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Macleods Pharmaceuticals Limited	33342-310	33342-0310-07
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Macleods Pharmaceuticals Limited	33342-311	33342-0311-07
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Preferred Pharmaceuticals Inc.	68788-8621	68788-8621-0168788-8621-0368788-8621-06+2 more
Lansoprazole	Lansoprazole 15 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Aurobindo Pharma Limited	65862-895	65862-0895-78

All 95 Lansoprazole NDCs

Other NDCs under ANDA 207167

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207167
Product	Strength	Form · route	Labeler	Product NDC
Lansoprazole	Lansoprazole 30 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Cardinal Health 107, LLC	55154-8340
Lansoprazole	Lansoprazole 15 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Aurobindo Pharma Limited	65862-895
Lansoprazole	Lansoprazole 30 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Aurobindo Pharma Limited	65862-896
Lansoprazole	Lansoprazole 30 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	NorthStar Rx LLC	72603-314